Aquatic Capital Management’s Immunocore IMCR Stock Holding History

Aquatic Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$558K	Buy	17,583 +16,461	+1,467%	+$487K	0.02%	757
2026 Q1	$33.8K	Sell	1,122 -23,853	-96%	-$772K	﹤0.01%	1214
2025 Q4	$867K	Buy	+24,975	New	+$882K	0.02%	587
2025 Q2	–	Sell	-2,709	Closed	-$80.4K	–	1379
2025 Q1	$80.4K	Buy	2,709 +1,309	+94%	+$39.3K	﹤0.01%	1090
2024 Q4	$41.3K	Sell	1,400 -9,500	-87%	-$300K	﹤0.01%	1194
2024 Q3	$339K	Sell	10,900 -23,000	-68%	-$837K	0.01%	718
2024 Q2	$1.15M	Buy	33,900 +21,000	+163%	+$1.07M	0.04%	372
2024 Q1	$839K	Buy	+12,900	New	+$885K	0.03%	425
2023 Q4	–	Sell	-6,500	Closed	-$337K	–	1468
2023 Q3	$337K	Buy	+6,500	New	+$385K	0.01%	567

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Aquatic Capital Management's IMCR Position: Q2 2026 in Review

Aquatic Capital Management increased its Immunocore (IMCR) stake by 1,467% in Q2 2026, buying an estimated $487K and bringing the position to 17,583 shares worth $558K. The position accounts for 0.02% of the portfolio, ranked #757.

Aquatic Capital Management first reported a position in IMCR in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.15M in Q2 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Aquatic Capital Management held 17,583 shares of Immunocore worth $558K as of Q2 2026.
Aquatic Capital Management bought 16,461 Immunocore shares in Q2 2026, an estimated $487K.
Immunocore made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #757 holding.
Aquatic Capital Management first reported a position in Immunocore in Q3 2023 and has held it in 9 quarters since.
Aquatic Capital Management's Immunocore position peaked at $1.15M in Q2 2024.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.